PDB Short entry for 1LFR
HEADER    TRANSFERASE                             12-APR-02   1LFR              
TITLE     THEORETICAL STRUCTURE OF HUMAN-CYCLIN DEPENDENT KINASE 5              
TITLE    2 (CDK5)                                                               
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: CELL DIVISION PROTEIN KINASE 5;                            
COMPND   3 CHAIN: A;                                                            
COMPND   4 SYNONYM: CYCLIN-DEPENDENT KINASE 5, CDK5;                            
COMPND   5 EC: 2.7.1.-                                                          
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                   
SOURCE   3 ORGANISM_COMMON: HUMAN                                               
KEYWDS    TRANSFERASE, SERINE/THREONINE-PROTEIN KINASE, ATP-BINDING,            
KEYWDS   2 CELL CYCLE, CELL DIVISION, PHOSPHORYLATION                           
EXPDTA    THEORETICAL MODEL                                                     
AUTHOR    K.NARAYANA,A.SRINIVASAREDDY,J.A.R.P.SARMA                             
REVDAT   1   24-APR-02 1LFR    0                                                
JRNL        AUTH   K.NARAYANA,A.SRINIVASAREDDY,J.A.R.P.SARMA                    
JRNL        TITL   THEORETICAL STRUCTURE OF HUMAN CYCLIN-DEPENDENT              
JRNL        TITL 2 KINASE 5 (CDK5)                                              
JRNL        REF    TO BE PUBLISHED                                              
JRNL        REFN                                                                
REMARK   1                                                                      
REMARK   1 REFERENCE 1                                                          
REMARK   1  AUTH   M.MEYERSON,G.H.ENDERS,C.L.WU,L.K.SU,C.GORKA,                 
REMARK   1  AUTH 2 C.NELSON,E.HARLOW,L.H.TSAI                                   
REMARK   1  TITL   A FAMILY OF HUMAN CDC2-RELATED PROTEIN KINASES               
REMARK   1  REF    EMBO J.                       V.  11  2909 1992              
REMARK   1  REFN   ASTM EMJODG  UK ISSN 0261-4189                               
REMARK   1 REFERENCE 2                                                          
REMARK   1  AUTH   C.E.ARRIS,F.T.BOYLE,A.H.CALVERT,N.J.CURTIN,                  
REMARK   1  AUTH 2 J.A.ENDICOTT,E.F.GARMAN,A.E.GIBSON,B.T.GOLDING,              
REMARK   1  AUTH 3 S.GRANT,R.J.GRIFFIN,P.JEWSBURY,L.N.JOHNSON,                  
REMARK   1  AUTH 4 A.M.LAWRIE,D.R.NEWELL,M.E.NOBLE,E.A.SAUSVILLE,               
REMARK   1  AUTH 5 R.SCHULTZ,W.YU                                               
REMARK   1  TITL   IDENTIFICATION OF NOVEL PURINE AND PYRIMIDINE                
REMARK   1  TITL 2 CYCLIN-DEPENDENT KINASE INHIBITORS WITH DISTINCT             
REMARK   1  TITL 3 MOLECULAR INTERACTIONS AND TUMOR CELL GROWTH                 
REMARK   1  TITL 4 INHIBITION PROFILES.                                         
REMARK   1  REF    J.MED.CHEM.                   V.  43  2797 2000              
REMARK   1  REFN   ASTM JMCMAR  US ISSN 0022-2623                               
REMARK   2                                                                      
REMARK   2 RESOLUTION. NOT APPLICABLE.                                          
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : NULL                                                 
REMARK   3   AUTHORS     : NULL                                                 
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: USED MODELER OF INSIGHTII,ACCELRYS        
REMARK   3  TO MODEL AND REFINE THE PROTEIN.                                    
REMARK   4                                                                      
REMARK   4 1LFR COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998                       
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-APR-2002.                
REMARK 100 THE RCSB ID CODE IS RCSB015906.                                      
REMARK 220                                                                      
REMARK 220 EXPERIMENTAL DETAILS                                                 
REMARK 220  EXPERIMENT TYPE                : THEORETICAL MODELLING              
REMARK 220                                                                      
REMARK 220 REMARK: COMPARATIVE MODELLING                                        
REMARK 225                                                                      
REMARK 225 THEORETICAL MODEL                                                    
REMARK 225 THE COORDINATES IN THIS ENTRY REPRESENT A MODEL STRUCTURE.           
REMARK 225 PROTEIN DATA BANK CONVENTIONS REQUIRE THAT CRYST1 AND                
REMARK 225 SCALE RECORDS BE INCLUDED, BUT THE VALUES ON THESE                   
REMARK 225 RECORDS ARE MEANINGLESS.                                             
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES                                       
REMARK 500                                                                      
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES              
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE               
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN               
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                 
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)              
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES: ENGH AND HUBER, 1991                                
REMARK 500                                                                      
REMARK 500  M RES CSSEQI ATM1   ATM2   ATM3                                     
REMARK 500    ALA A 148   C   -  N   -  CA  ANGL. DEV. = 17.0 DEGREES           
REMARK 500    ARG A 149   CA  -  CB  -  CG  ANGL. DEV. = 24.7 DEGREES           
REMARK 500    ARG A 149   CB  -  CG  -  CD  ANGL. DEV. = 24.7 DEGREES           
REMARK 500    ARG A 149   N   -  CA  -  C   ANGL. DEV. = 18.5 DEGREES           
REMARK 500    ARG A 149   C   -  N   -  CA  ANGL. DEV. =-31.8 DEGREES           
REMARK 500    ARG A 149   CA  -  C   -  N   ANGL. DEV. =-16.4 DEGREES           
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: TORSION ANGLES                                             
REMARK 500                                                                      
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        PSI       PHI                                   
REMARK 500    ASP A  38     -143.90     95.62                                   
REMARK 500    ARG A 149      116.04    149.03                                   
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS                                         
REMARK 500                                                                      
REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH          
REMARK 500 CIS AND TRANS CONFORMATION.  CIS BONDS, IF ANY, ARE LISTED           
REMARK 500 ON CISPEP RECORDS.  TRANS IS DEFINED AS 180 +/- 30 AND               
REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES.                                  
REMARK 500                                 MODEL     OMEGA                      
REMARK 500 ALA A  148    ARG A  149                  116.79                     
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: 1E1V   RELATED DB: PDB                                   
REMARK 900 1E1V CHAIN A HAS 59% SEQUENCE SIMILARITY (2E-98) WITH CDK5           
REMARK 900 RELATED ID: 1QMZ   RELATED DB: PDB                                   
REMARK 900 1QMZ CHAIN A HAS 59% SEQUENCE SIMILARITY (4E-98) WITH CDK5           
DBREF  1LFR A    1   292  UNP    Q00535   CDK5_HUMAN       1    292             
SEQRES   1 A  292  MET GLN LYS TYR GLU LYS LEU GLU LYS ILE GLY GLU GLY          
SEQRES   2 A  292  THR TYR GLY THR VAL PHE LYS ALA LYS ASN ARG GLU THR          
SEQRES   3 A  292  HIS GLU ILE VAL ALA LEU LYS ARG VAL ARG LEU ASP ASP          
SEQRES   4 A  292  ASP ASP GLU GLY VAL PRO SER SER ALA LEU ARG GLU ILE          
SEQRES   5 A  292  CYS LEU LEU LYS GLU LEU LYS HIS LYS ASN ILE VAL ARG          
SEQRES   6 A  292  LEU HIS ASP VAL LEU HIS SER ASP LYS LYS LEU THR LEU          
SEQRES   7 A  292  VAL PHE GLU PHE CYS ASP GLN ASP LEU LYS LYS TYR PHE          
SEQRES   8 A  292  ASP SER CYS ASN GLY ASP LEU ASP PRO GLU ILE VAL LYS          
SEQRES   9 A  292  SER PHE LEU PHE GLN LEU LEU LYS GLY LEU GLY PHE CYS          
SEQRES  10 A  292  HIS SER ARG ASN VAL LEU HIS ARG ASP LEU LYS PRO GLN          
SEQRES  11 A  292  ASN LEU LEU ILE ASN ARG ASN GLY GLU LEU LYS LEU ALA          
SEQRES  12 A  292  ASP PHE GLY LEU ALA ARG ALA PHE GLY ILE PRO VAL ARG          
SEQRES  13 A  292  CYS TYR SER ALA GLU VAL VAL THR LEU TRP TYR ARG PRO          
SEQRES  14 A  292  PRO ASP VAL LEU PHE GLY ALA LYS LEU TYR SER THR SER          
SEQRES  15 A  292  ILE ASP MET TRP SER ALA GLY CYS ILE PHE ALA GLU LEU          
SEQRES  16 A  292  ALA ASN ALA GLY ARG PRO LEU PHE PRO GLY ASN ASP VAL          
SEQRES  17 A  292  ASP ASP GLN LEU LYS ARG ILE PHE ARG LEU LEU GLY THR          
SEQRES  18 A  292  PRO THR GLU GLU GLN TRP PRO SER MET THR LYS LEU PRO          
SEQRES  19 A  292  ASP TYR LYS PRO TYR PRO MET TYR PRO ALA THR THR SER          
SEQRES  20 A  292  LEU VAL ASN VAL VAL PRO LYS LEU ASN ALA THR GLY ARG          
SEQRES  21 A  292  ASP LEU LEU GLN ASN LEU LEU LYS CYS ASN PRO VAL GLN          
SEQRES  22 A  292  ARG ILE SER ALA GLU GLU ALA LEU GLN HIS PRO TYR PHE          
SEQRES  23 A  292  SER ASP PHE CYS PRO PRO                                      
HELIX    1   1 PRO A   45  LEU A   58  1                                  14    
HELIX    2   2 LEU A   87  ASP A   92  1                                   6    
HELIX    3   3 ASP A   99  ARG A  120  1                                  22    
HELIX    4   4 LYS A  128  GLN A  130  5                                   3    
HELIX    5   5 GLY A  146  ALA A  150  5                                   5    
HELIX    6   6 PRO A  169  PHE A  174  1                                   6    
HELIX    7   7 THR A  181  ASN A  197  1                                  17    
HELIX    8   8 ASP A  207  GLY A  220  1                                  14    
HELIX    9   9 SER A  229  LEU A  233  5                                   5    
HELIX   10  10 SER A  247  VAL A  252  1                                   6    
HELIX   11  11 ASN A  256  LEU A  267  1                                  12    
HELIX   12  12 SER A  276  HIS A  283  1                                   8    
HELIX   13  13 PRO A  284  SER A  287  5                                   4    
SHEET    1   A 5 TYR A   4  GLU A  12  0                                        
SHEET    2   A 5 THR A  17  ASN A  23 -1  O  LYS A  20   N  GLU A   8           
SHEET    3   A 5 ILE A  29  VAL A  35 -1  O  LEU A  32   N  PHE A  19           
SHEET    4   A 5 LYS A  75  GLU A  81 -1  O  LEU A  76   N  VAL A  35           
SHEET    5   A 5 LEU A  66  SER A  72 -1  N  SER A  72   O  LYS A  75           
SHEET    1   B 3 GLN A  85  ASP A  86  0                                        
SHEET    2   B 3 LEU A 132  ILE A 134 -1  O  ILE A 134   N  GLN A  85           
SHEET    3   B 3 LEU A 140  LEU A 142 -1  O  LYS A 141   N  LEU A 133           
CRYST1    1.000    1.000    1.000  90.00  90.00  90.00 P 1           1          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      1.000000  0.000000  0.000000        0.00000                         
SCALE2      0.000000  1.000000  0.000000        0.00000                         
SCALE3      0.000000  0.000000  1.000000        0.00000